Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia

Blood Adv. 2021 Dec 14;5(23):5215-5219. doi: 10.1182/bloodadvances.2021005164.
No abstract available

MeSH terms

  • Aniline Compounds
  • Child
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Pyrazines*
  • fms-Like Tyrosine Kinase 3 / genetics

Substances

  • Aniline Compounds
  • Pyrazines
  • gilteritinib
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3